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Abstract
Introduction: Residual cancer following breast conserving surgery increases the risk of local recurrence and
mortality. Margin assessment presents an unmet clinical need. Breast tissue is markedly heterogeneous, which
makes distinguishing small foci of cancer within the spectrum of normal tissue potentially challenging. This is
further complicated by the heterogeneity as a function of menopausal status. Optical spectroscopy can provide
surgeons with intra-operative diagnostic tools. Here, we evaluate ex-vivo breast tissue and determine which sources
of optical contrast have the potential to detect malignancy at the margins in women of differing breast
composition.
Methods: Diffuse reflectance spectra were measured from 595 normal and 38 malignant sites from the margins of
104 partial mastectomy patients. All statistical tests were performed using Wilcoxon Rank-Sum tests. Normal and
malignant sites were compared before stratifying the data by tissue type and depth and computing statistical
differences. The frequencies of the normal tissue types were separated by menopausal status and compared to the
corresponding optical properties.
Results: The mean reduced scattering coefficient, < μs’ >, and concentration of total hemoglobin, [THb]), showed
statistical differences between malignant (< μs’ > : 8.96 cm
-1 ±2 . 2 4 MAD, [THb]: 42.70 μM±2 9 . 3 1 MAD)c o m p a r e dt o
normal sites (< μs’ >:7 . 2 9c m
-1 ±2 . 1 5 MAD,[ T H b ] :3 2 . 0 9μM ± 16.73MAD)( P < 0.05). The sites stratified according to
normal tissue type (fibro-glandular (FG), fibro-adipose (FA), and adipose (A)) or disease type (invasive ductal carcinoma
(IDC) and ductal carcinoma in situ (DCIS)) showed that FG exhibited increased < μs’ > and A showed increased
[b-carotene] within normal tissues. Scattering differentiated between most malignant sites, DCIS (9.46 cm
-1 ± 1.06MAD)
and IDC (8.00 cm
-1 ±1 . 8 1 MAD), versus A (6.50 cm
-1 ±1 . 9 5 MAD). [b-carotene] showed marginal differences between DCIS
(19.00 μM±6 . 9 3 MAD, and FG (15.30 μM±5 . 6 4 MAD). [THb] exhibited statistical differences between positive sites
(92.57 μM ± 18.46MAD) and FG (34.12 μM ± 22.77MAD), FA (28.63 μM±1 4 . 1 9 MAD), and A (30.36 μM ± 14.86MAD). The
diagnostic ability of the optical parameters was affected by distance of tumor from the margin as well as menopausal
status. Due to decreased fibrous content and increased adipose content, normal sites in post-menopausal patients
exhibited lower < μs’ >, but higher [b-carotene] than pre-menopausal patients.
Conclusions: The data indicate that the ability of an optical parameter to differentiate benign from malignant
breast tissues may be dictated by patient demographics. Scattering differentiated between malignant and adipose
sites and would be most effective in post-menopausal women. [b-carotene] or [THb] may be more applicable in
pre-menopausal women to differentiate malignant from fibrous sites. Patient demographics are therefore an
important component to incorporate into optical characterization of breast specimens.
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According to the 2009 American Cancer Society statistics,
there were an estimated 192,370 individuals diagnosed
with invasive breast cancer and 62,280 with in situ breast
cancer in the United States [1]. Treatment for breast can-
cer involves a multi-disciplinary approach incorporating
surgery (lumpectomy, mastectomy and/or removal of axil-
lary lymph nodes), chemotherapy, directed biologic ther-
apy and/or radiation therapy. Breast conserving surgery
(BCS), also known as a lumpectomy or partial mastect-
omy, is generally considered to be the recommended sur-
gical choice for women with early stage breast cancer
(Stages 0, I, II) and for those with Stage II to III disease
who undergo successful neo-adjuvant treatment to reduce
their tumor burden [2,3]. Breast Conserving Therapy
(BCT) refers to BCS followed by radiation therapy. The
rate of BCT versus mastectomy is regionally variable and
partly dependent on the patients’ breast to tumor size
ratio. On average, between 50 and 75% of patients with
breast cancer receive BCT [4,5]. Traditionally, analyses of
multiple randomized clinical trials comparing patients
who received BCT to those with mastectomy have shown
equivalent long-term survival [6]. Recently, however, the
meta-analyses by the Early Breast Cancer Trialists group
has shown that for every four women who develop a local
recurrence after BCT there is one potential mortality; evi-
dence supporting the need to reduce the risk of local
recurrence through complete tumor excision [7,8].
In BCS, the surgeon attempts to excise the cancerous
area along with a margin of normal tissue, while conser-
ving as much breast volume as possible. The specimen is
viewed as a cube with six margins: anterior, posterior or
deep, medial, lateral, inferior and superior. The surgeon,
immediately upon removal of the tissue, uses surgical clips
and/or sutures to orient the specimen for pathology. The
excised tissue and any additional margin shavings are sent
to surgical pathology for inking which further delineates
the six margins, followed by a thorough microscopic eva-
luation. At Duke University Medical Center (DUMC), a
margin is denoted as positive if malignant cells are found
on the ink used by the pathologists; close if malignant
cells are found within 2 mm of the margin, and negative if
there are no malignant cells within 2 mm of the margin.
The final surgical margin status is a determinant of local
recurrence, thus patients are advised to have a re-excision
if disease is found within 2 mm of the margin [9,10]. The
quoted rates of second surgeries vary in the literature and
range from 12% to as high as 60% [2,8,10,11].
Pathologic touch preparation cytology and frozen sec-
tion analyses are used in a select number of hospitals
for intra-operative breast margin assessment and have
been shown to have limitations, motivating the clinical
need for improved intra-operative margin assessment
tools [12]. Touch-prep cytology has a sensitivity ranging
from 75 to 100% and allows the entire margin to be sur-
veyed but requires an on-site trained pathologist and
can only detect tumor cells extending all the way up to
the surgical margin; it is unable to identify close margins
[9,13,14]. The sensitivity of frozen section analysis
ranges from 59 to 91% [15-18]. This technique also
requires an on-site trained pathologist, performs poorly
with fatty breast tissue and typically samples only a very
small portion of the surgical margin [19].
A number of academic [13,20-24] and commercial
[25-27] groups have worked on or are developing tools
for intra-operative assessment of breast margins. Dune
Medical has developed a pen-like probe called the
MarginProbe™, which uses radio waves to measure the
electromagnetic properties of breast tissue over a 7 mm
diameter area with a 1 mm sensing depth. Their device
was reported to have a sensitivity and specificity of 70%
and 70%, respectively, and varied with the size of cancer
features [28].
Pioneering optical studies to characterize breast tumors
were carried out by Bigio et al. [22] in which they used
reflectance spectroscopy in the ultraviolet (UV) to visible
(VIS) range to evaluate sites within the tumor bed in 24
patients (13 cancer and 59 normal sites). This work sug-
gested an important role for optical spectroscopy in mar-
gin analysis. Keller et al. published on the ability of
diffuse reflectance and fluorescence spectroscopy to
detect cancerous sites on excised breast tumors in 32
patients (145 normal and 34 individual tumor sites), and
reported a sensitivity and specificity of 85% and 96%,
respectively, for classifying individual sites (not margins)
[24]. Volynskaya et al.u s e dm o d i f i e dd i f f u s i o nt h e o r y
and multivariate curve resolution, to extract absorption
and scattering information from 104 reflectance and
fluorescence spectra in breast biopsies from 17 patients
to achieve a sensitivity and specificity of 100% and 96%
[29]. Haka et al. utilized Raman spectroscopy from
tumor sites on freshly sliced lumpectomy specimens in
21 patients (123 normal and 6 malignant tissue sites) and
exploited fat and collagen contrast to achieve a sensitivity
and specificity of 83% and 93%, respectively for classify-
ing individual sites [23]. Nguyen et al. [20] demonstrated
that optical coherence tomography detects ex-vivo mar-
gin positivity in 20 patients (11 positive/close margins
and 9 negative margins), with a sensitivity and specificity
of 100% and 82%, respectively by exploiting scattering
associated with increased cell density.
Our group recently published the results of a quantita-
tive diffuse reflectance spectroscopy technique to non-
destructively image entire lumpectomy margins in 48
patients [8,30]. Successive placement of a multi-channel
probe samples an area of approximately 2 × 4 cm, with
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cut for pathology) and sensing depth of 0.5 to 2.2 mm
(450 to 600 nm) (on a par with the pathologic criterion
for clear margins) [31]. The diffuse reflectance spectra
p e rs i t ew e r ea n a l y z e dw i t haf e a t u r ee x t r a c t i o na l g o -
rithm based on a fast, scalable Monte Carlo model
developed by our group [32,33] to quantitatively deter-
mine absorption and scattering contrast in the breast.
The sources of contrast were used to create tissue com-
position maps and then were applied to a decision-tree
model to differentiate positive from negative margins.
This margin level approach resulted in a sensitivity and
specificity of 79.4% and 66.7% respectively on 55 mar-
gins from 48 patients [8,31].
Normal breast tissue is markedly heterogeneous, which
makes distinguishing small foci of cancer within the spec-
trum of normal tissue potentially challenging. This is
further complicated by the heterogeneity as a function of
menopausal status. The goal of the work presented here
was to evaluate the site level optical properties of patho-
logically confirmed normal and malignant ex-vivo human
breast tissue sites, and to determine which sources of
optical contrast have the potential to detect malignancy
on margins in women of differing normal and malignant
breast composition. Our data show how ex-vivo optical
properties of positive and close sites on breast tumor
margins are strongly dependent on breast tissue compo-
sition and patient demographics, which should be
accounted for in developing classification algorithms.
The results of this paper will provide an understanding of
the optical contrast from individual pixels which will be
informative for both a site level and margin level method
of margin assessment.
Materials and methods
Clinical protocol
An ex-vivo study using diffuse optical spectroscopy to
evaluate partial mastectomy specimens in patients under-
going surgery for breast malignancies was approved by
t h eI n s t i t u t i o n a lR e v i e wB o a r da tD u k eU n i v e r s i t ya s
detailed in previous publications [8,31]. Informed consent
was obtained from eligible patients undergoing a partial
mastectomy (lumpectomy). The surgeries were per-
formed on 104 patients by one of five collaborating
s u r g e o n sa tt h eD u k eU n i v e r s i t yA m b u l a t o r yS u r g e r y
Center. The optical study was performed post excision
and did not alter the standard operating procedures.
The surgeons performed sentinel lymph node dissection
in addition to the partial mastectomy on a subset of
patients. For sentinel lymph node dissection, Lympha-
zurin™ (United States Surgical, a division of Tyco Health-
care Group LP, Norwalk, CT, USA) was injected into the
subareolar or peri-tumoral area in order to identify the
draining lymph nodes for the respective cancers. In these
cases, the Lymphazurin™ was also found within the
lumpectomy margins in varying degrees, the presence of
which was recorded for each consented patient. Patient
demographics were recorded, including menopausal sta-
tus. Women were designated as post-menopausal if they
had one of the following: either a bilateral salpingo-
oopherectomy or lack of a menstrual cycle for greater
than one year.
In each partial mastectomy case, the surgeon removed
the specimen, then placed clips and sutures to orient the
specimen for pathological assessment. This clinical pro-
tocol and margin level pathologic processing is described
in more detail in a previous publication by Wilke et al.
[8]. Diffuse reflectance (DR) spectral imaging was per-
formed on the margins of the lumpectomy specimens
between 10 and 20 minutes after excision. Margins were
selected based on specimen mammograms and surgeon
recommendations for potentially positive margins. Typi-
cally, spectroscopic data were measured from one margin
per case and when time permitted, measured from up to
five margins before the end of the operation. For a more
detailed analysis of tissue contrast with respect to differ-
ent breast tissue types, an additional 6 to 10 sites were
randomly inked orange (Figure 1A) on one of the imaged
margins. In a few instances, sites were inked on two mar-
gins. Tissue composition at those specific sites was deter-
mined via a separate microscopic evaluation by the study
pathologist (JG). The margins with inked research dots
were processed as seen in Figure 1 and as described in
the Histopathology section below.
Of the 854 sites from 105 margins (104 patients), the
pathologist was unable to microscopically identify
the inked site to generate a diagnosis for 91 sites. From
the remaining 763 sites, 94% (715) were normal and 6%
(48) were positive or close for malignant disease. Seven-
teen percent (120) of the normal sites and 2% (10) of the
malignant sites were excluded. Reasons for exclusion
included excess Lymphazurin™, a missing diagnosis,
unknown distance of the tumor from the margin, or poor
optical signal to noise resulting in extreme outliers which
were more than three times the inter-quartile range
(IQR) below the first quartile or above the third quartile
of all sites. Sites were considered to have too much Lym-
phazurin™ if intensity of the diffuse reflectance spectrum
at 600 nm was lower than the intensity at 450 nm, indi-
cating that Lymphazurin™ overwhelmed the hemoglobin
absorption. Removing these samples resulted in 595 nor-
mal sites and 38 malignant sites from 101 margins (100
patients) retained for the final analysis. The first stage of
the analysis to show high level tissue contrast was per-
formed between all malignant and normal sites from 101
margins (100 patients). The second stage of the study to
look at the effect of tissue type and disease depth exam-
ined only the retained sites with a predominant tissue
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one patient and one margin that contained heteroge-
neous sites leaving 100 margins from 99 patients (32
malignant and 408 normal sites). Patients without a
known menopausal status or who were peri-menopausal
(seven margins, six patients) were excluded from the
third stage of the analysis which only included pre- and
post-menopausal normal samples. This resulted in 94
margins from 93 patients (553 normal sites).
Histopathology
Routine histopathology was performed on each of the
specimens. In Figure 1A, B, the green margin dots and
orange research dots are shown on a margin. To obtain
the site level histology, each specimen underwent trans-
verse sectioning into 3 mm thick slices. Figure 1C shows
a 3 mm section containing two research dots (1 and 2).
The transverse slice has ink on the borders correspond-
ing to the specimen’s surgical orientation. Each slice was
further sectioned so that a dot was contained in an
approximately 20 × 10 × 3 mm piece of tissue, which was
then embedded in paraffin wax (Figure 1D). A 5 μm
thick slice was then taken from the embedded specimen,
stained with hemotoxylin & eosin (H&E) and microscopi-
cally evaluated by the study pathologist (JG) (Figure 1E).
A site level diagnosis was generated for each inked loca-
tion. Because the theoretical sensing depth of the probe
ranged from 0.5 to 2.2 mm (see Clinical measurements of
diffuse reflectance spectra), the study pathologist also pro-
vided a quantitative measure of the distance of malig-
nancy from the margin ranging from 0 mm to 2 mm.
Malignant sites were classified by the distance of malig-
nant cells from the surgical margin ("positive” = cancer at
surface, “close” = between 0 to 2 mm from the surface) as
well as the type of cancer present. For ‘close’ sites, the
actual distance of the malignant cells from the surgical
margin was recorded. The type of cancer was specified as
IDC, invasive lobular carcinoma (ILC), DCIS, or lobular
carcinoma in situ (LCIS). Normal tissues were classified
according to the predominant tissue type present. Due to
the heterogeneity of breast tissue, the normal sites were
broken down into fibro-glandular (FG), fibro-adipose
(FA), adipose (A), fibro-cystic change (FCC), fibrous (F),
fat necrosis (FN), or sites with mixed tissue types (Mx).
Samples with a predominant tissue type and unusually
prominent vessels or hemorrhage were categorized as
vessels (V).
Clinical measurements of diffuse reflectance spectra
This study utilized instrumentation from Jobin-Yvon
HORIBA (Edison, NJ, USA) that included a 450 W
Xenon arc lamp, a double excitation monochromator
(Gemini 180, JY HORIBA), an imaging spectrograph
(TRIAX 320, Jobin-Yvon HORIBA) and a Peltier-cooled
CCD (Symphony, Jobin-Yvon HORIBA). This study was
performed using an in-house designed multi-channel
fiber-optic probe manufactured by RoMack, Inc.
(Williamsburg, VA, USA). The multi-channel probe had
eight individual channels, where each channel consisted
of a core of 19 hexagonally packed illumination fibers
and 4 collection fibers arranged at the corners of the
illumination core. All fibers were 200 μm in diameter
with a numerical aperture of 0.22. The breast specimen,
once excised, was oriented in a Plexiglass™ box using
the clips and sutures to maintain orientation with the
surgeon and pathology. The channels of the probe were
then interfaced with the Plexiglass™ box via an alumi-
num adaptor. The holes in the Plexiglass™ box were
spaced 5 mm apart (center-to-center), which means that
the tissue in the box was imaged with a 5 mm spatial
resolution. Diffuse reflectance spectra were measured
simultaneously from eight holes (or pixels) for each pla-
cement of the multi-channel probe in the Plexiglass™
box. To ensure that the entire margin was sampled, the
Figure 1 Photograph of an actual margin after imaging and pathological methodology. (A) The six orange dots provide the location of
inked sites and the four green dots denote the boundaries of the margin used for pathologic co-registration and diagnoses. Four margin dots
(green) denote the corners of the measured margin while the eight orange dots denote the research dots (B). A transverse slice is taken from
the specimen with the margins inked for orientation (C). Each research dot is embedded in a paraffin block from routine processing (D).A5μm
section is taken from the paraffin block, stained and examined under a microscope by a specialized breast pathologist (E).
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face of the specimen such that one spectrum was even-
tually obtained from each hole of the box. To ensure
that there was no optical cross-talk between adjacent
probes during any single measurement of eight pixels,
the channels were arranged in a 4 × 2 array with a cen-
ter-to-center spacing of 10 mm for each channel. This
overall procedure ensured that data were collected uni-
formly and repeatedly over the tissue surface, with mini-
mal cross-talk between channels. The average margin
was covered with 64 holes (or pixels), which means that
on average the entire margin surface was sampled with
eight placements of the multi-channel probe. A custom
LabVIEW (National Instruments Corporation, Austin,
TX, USA) application was used to control data collec-
tion and keep track of the original spatial locations of
each diffuse reflectance measurement on the tissue sur-
face, so that accurate spatial maps of the tissue could be
reconstructed after completion of imaging. The imaging
procedure is described in detail in our previous publica-
tions [8,31,34]. After imaging, 6 to 10 tissue sites (or
pixels) were randomly chosen and inked with a wooden
dowel inserted through the Plexiglass™ box holes for the
detailed pathological analysis described in Histopathol-
ogy. The sensing depth of the multi-channel probe was
previously simulated. These simulations were carried
out using a weighted photon Monte Carlo model, pre-
viously described by Liu et al. [35] and Zhu et al. [36].
The theoretical sensing depth was determined using the
weighted visiting frequency as a function of depth as
described by Bydlon et al. [31]. Based on the simulations
over the wavelength range of 450 to 600 nm, the sensing
depth of the multi-channel probe varied with tissue
type: 0.5 to 1.5 mm in positive tissues, 0.7 to 2.2 mm in
adipose tissues, and 0.6 to 1.5 mm in fibro-glandular
tissue [31].
We have also evaluated the reproducibility and accu-
racy of these diffuse reflectance measurements. Bydlon
et al. reported the coefficient of variation (s/μ) calculated
from 10 repeated measurements for the system [31]. The
median coefficient of variation was calculated and was
found to be less than 0.11 for all extracted parameters
(b-carotene, < μs’ >, THb, b-carotene/< μs’ >, THb/< μs’
>, and b-carotene/THb) indicating little deviation from
the mean in all measurements. Using tissue mimicking
phantoms, accuracy for determining the underlying tissue
compositional features was found to be 5.57 ± 3.89% for
[THb], 14.99 ± 13.6% for Crocin (similar absorption to
[b-carotene]), and 9.81 ± 6.89% for < μs’> [31]. These
errors in extraction accuracy for [THb], [Crocin] and <
μs’> were less than the percent difference observed
between positive vs. adipose tissue; the errors in [THb]
and < μs’> were less than the percent difference observed
between positive vs. fibro-glandular tissue [31].
After spectral imaging was completed, calibration mea-
surements were made on a Spectralon reflectance standard
(Labsphere, North Sutton, NH, USA) to account for the
wavelength dependence and throughput of the system, as
described in greater detail in previous studies [8,36,37].
The spectral imaging system is also further described in
previous publications by our group [31,34,38].
Extraction of tissue optical properties
Optical properties of the measured tissue were extracted
from the diffuse reflectance spectra using a fast, scalable
Monte Carlo inverse model [33]. The Monte Carlo model
was used to analyze the diffuse reflectance spectra from
4 5 0t o6 0 0n m .T h es t r o n g e s ti n t r i n s i ca b s o r b e r si nt h i s
range were assumed to be oxygenated and de-oxygenated
hemoglobin, as well as b-carotene. Lymphazurin™ was
included as an extrinsic absorber in the model as pre-
viously described [39]. An arbitrary absorber was included
by modeling the extinction as a Gaussian with a center
mean wavelength of 515 nm and a standard deviation of
10 nm, and was used to account for the difference in
shape between the tabulated absorption of b-carotene and
the absorption of b-carotene in tissue [32,39]. This devia-
tion in fit was seen between 500 to 530 nm. The magni-
tude of the Gaussian function was previously found to be
highly correlated (Pearson’s correlation coefficient of 0.9)
to [b-carotene]. In this previous study, the addition of the
Gaussian function improved the fits but did not signifi-
cantly affect the conclusions regarding the extracted para-
meters when compared to the case where the Gaussian
absorber was not used [32]. The concentrations of
b-carotene, oxygenated hemoglobin, de-oxygenated hemo-
globin, and Lymphazurin™were extracted using the model.
Other parameters such as hemoglobin saturation and THb
were derived from the concentrations of oxygenated and
de-oxygenated hemoglobin. The wavelength dependent
reduced scattering coefficient, μs’ (l), was extracted from
the model and the mean wavelength-averaged value, < μs’
>, was calculated to describe the scattering properties of
the probed tissue volume.
Statistical analysis
The distributions of the optical properties were empiri-
cally summarized by the median, median absolute
deviance (MAD), IQR, and Tukey whiskers as 1.5*IQR.
Optical properties were first compared between all malig-
nant and normal sites from the 101 retained margins.
The optical properties were then stratified according to
the predominant tissue type and pair wise comparisons
were made using Wilcoxon Rank-Sum tests and applying
a Bonferroni correction factor for multiple comparisons.
The Inverse Monte Carlo model, statistical comparisons
and figures were generated using MATLAB™ (MatWorks
Inc., Natick, Massachusetts, USA).
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The primary aim of this study was to evaluate the VIS
optical properties of normal and malignant breast tis-
sues to understand the effect of the normal tissue types,
different disease types, depth of disease, and patient
demographics on the extracted optical properties. The
38 malignant samples were comprised of IDC (n = 22),
DCIS (n =1 2 ) ,L C I S( n =3 ) ,a n dI L C( n =1 )( T a b l e1 ) .
The malignant sites at 0 mm are considered positive by
standard pathology; the sites from 0
+ to 1 mm or 1
+ to
2 mm are considered pathologically “close”. The malig-
nant sites were separated by distance from the margin
as follows: on ink at 0 mm (n =1 0 ) ,0
+ to 1 mm of the
margin (n =1 7 ) ,1
+ t o2m mf r o mt h em a r g i n( n = 11).
The 595 normal sites were divided into adipose (A) (n =
324), mixed tissue samples (Mx) (n = 112), vessel sam-
ples (V) (n = 64), fibro-adipose (FA) (n =6 0 ) ,f i b r o -
glandular (FG) (n =2 4 ) ,f i b r o c y s t i cc h a n g e( F C C )( n =
4), fibrous (F) (n = 6), and fat necrosis (FN) (n =1 )a s
shown in (Table 1). Of these normal samples, 142 were
from pre-menopausal patients and 411 were from post-
menopausal patients.
Optical contrast: malignant vs. normal
Optical properties were compared between normal and
malignant sites and the results are shown in Figure 2.
The malignant sites were comprised of all “positive” and
“close” (0 to 2 mm) sites representing several disease
types (IDC, DCIS, ILC, and LCIS), and the normal sites
included the entire 595 normal tissue types listed in
Table 1. Scattering, < μs’ >, was significantly increased in
malignant sites (8.96 cm
-1 ±2 . 2 4 MAD) compared to nor-
mal sites (7.29 cm
-1 ±2 . 1 5 MAD)( P = 0.0027, Figure 2A).
Furthermore, [THb] was also significantly increased in
malignant sites (42.70 μM ± 29.31MAD) compared to nor-
mal (32.09 μM ± 16.73MAD)s i t e s( P = 0.031, Figure 2C).
However, [b-carotene] could not differentiate malignant
tissues from benign tissues (P = 0.87, Figure 2B).
Optical contrast: normal heterogeneity
Mixed tissues and vessels were excluded from this ana-
lysis because the fractional composition of adipose,
glands, and fibrous tissue within each site was not speci-
fied by pathology. Fibrous, fibrocystic change, and fat
necrosis sites were excluded due to their respective
small sample sizes. The Wilcoxon-rank sum P-values
were corrected for three comparisons. In Figure 3, the
normal sites stratified according to the predominant tis-
s u et y p es h o w e dt h a t<μs’> increased with increased
fibrous content. All three predominant tissue types
showed statistically significant scattering differences
f r o mo n ea n o t h e r( F Gv .A ,a d j .P < 0.0001; FG v. FA,
adj. P = 0.011; A v. FA, adj. P = 0.0026). The median
scattering and median absolute deviance for the normal
tissue types were as follows: FG (11.61 cm
-1 ±3 . 4 4 MAD),
FA (7.80 cm
-1 ±2 . 8 6 MAD), and A (6.50 cm
-1 ±
1.95MAD). [b-carotene] was higher in adipose (adj. P =
0.017) than in fibro-glandular sites. Marginal differences
in [b-carotene] are noted between FG and FA (nominal
P = 0.045), but do not reach statistical significance after
accounting for multiple comparisons. The resulting
median [b-carotene] values were as follows: FG (15.30
μM ± 5.64MAD), FA (17.45 μM ± 6.88MAD), and A
(18.75 μM ± 5.74MAD). The concentration of
total hemoglobin, [THb], did not show statistical differ-
ences between FG (34.12 μM ± 22.77MAD), FA (28.63
μM ± 14.19MAD), or A (30.36 μM ± 14.86MAD).
Optical contrast: malignant vs. normal variants
This portion of the study focused on a two factor analysis
of disease type and disease depth, the data for which is
shown in Figure 3. Because normal sites showed a range
of values for each parameter (< us’ >, [THb], [b-carotene]),
we also wanted to examine the range of values obtained
from different malignant tissue types, such as IDC and
DCIS. The resulting P-values were adjusted by accounting
for six comparisons. Figure 3 shows the normal variants
fibro-glandular (FG), fibro-adipose (FA), and adipose (A)
in green, as well as the malignant variants (IDC in red and
DCIS in black separated by disease depth). ILC and LCIS
were excluded due to the small sample size. For the first
part of the analysis, all IDC depths were combined and
also all DCIS depths were combined (combined depths are
not shown in Figure 3). Overall, FG exhibited the highest
median scattering, followed by DCIS (9.46 cm
-1 ±
1.06MAD), IDC (8.00 cm
-1 ±1 . 8 1 MAD), FA, then A.
The highest median [b-carotene] was observed in DCIS
Table 1 Classification of the ex-vivo sites for normal and
malignant tissue types
Normal 595 Malignant 38
Adipose (A) 324 0 mm 10
Mixed tissue types (Mx) 112 IDC 8
Fibro-adipose (FA) 60 DCIS 2
Vessels (V) 64 0
+ to 1 mm 17
Fibro-glandular (FG) 24 IDC 9
Fibrous (F) 6 DCIS 5
Fibro-cystic change (FCC) 4 ILC 1
Fat Necrosis (FN) 1 LCIS 2
1
+ to 2 mm 11
IDC 5
DCIS 5
LCIS 1
The malignant sites are stratified according to disease type (IDC, DCIS, ILC, or
LCIS) and by depth. Malignant sites at 0 mm are considered positive; sites
from 0
+ to 1 mm or 1
+ to 2 mm are considered close. DCIS, ductal carcinoma
in situ; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; LCIS,
lobular carcinoma in situ.
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Page 6 of 13(19.00 μM ± 6.93MAD), followed by A, FA, FG then IDC
sites (13.89 μM±8 . 2 9 MAD). Comparing the concentra-
tions of total hemoglobin across these different normal
and disease tissue types resulted in DCIS exhibiting the
highest median value (57.42 μM ± 21.58MAD), followed by
IDC (38.89 μM ± 26.15MAD), FG, A and FA. Scattering, <
μs’ >, could statistically differentiate between IDC and A
(adj. P = 0.035), and DCIS and A (adj. P = 0.0012). [THb]
was able to separate DCIS from A (adj. P = 0.029). While
several parameters could not distinguish between specific
variants when applying the Bonferroni correction for mul-
tiple comparisons, unadjusted P-values did show several
additional differences among variants. For example, scat-
tering was observed to be higher in FG than in IDC with
an unadjusted P-value of P = 0.044; DCIS exhibited
increased [b-carotene] compared to FG with an un-
adjusted P-value of P = 0.028. [THb] was also increased
in DCIS compared to FA with an unadjusted P-value of
P = 0.023.
The second factor in the analysis involved evaluating
how optical properties varied with depth in order to
determine the contribution of the “intervening” normal
tissue to the optical evaluation. The type of normal tissue
between the margin and malignancy was not specifically
identified by the pathologist in this study. The disease
types are shown in Figure 3 as positive sites (0 mm),
close sites within 1 mm of the margin (0
+ to 1 mm), and
close sites between 1 to 2 mm from the margin (1
+ to
2 mm). Positive DCIS sites (0 mm) are not shown in
Figure 3 due to the small sample size (n = 2). For this
analysis, IDC and DCIS samples were combined and
grouped according to depth of malignancy as the sample
size was not large enough to statistically evaluate optical
parameters by both disease type and depth. This group-
ing of IDC and DCIS according to depth of malignancy
showed that < μs’> was highest within the close sites (0
+
to 1 mm) (11.41 cm
-1 ±2 . 6 1 MAD), followed by positive
sites (0 mm) (8.60 cm
-1 ± 1.33MAD), and close sites (1
+ to
Figure 2 Boxplots of the extracted parameters for malignant versus non-malignant tissues. (A) < μs’ >, (B) b-carotene concentration, and
(C) total hemoglobin concentration. To improve visualization of the distributions of the extracted parameters, the boxplots were scaled to a
maximum of 20 cm
-1 for < μs’ >, 50 μM for [b-carotene] and 150 μM for [THb]. The P-values are displayed for the Wilcoxon Rank Sum tests.
Figure 3 Boxplots of (A) < μs’ >, (B) [b-carotene], and (C) [THb] for normal and malignant tissue subcategories. Normal tissue consists of
fibro-glandular (FG), fibro-adipose (FA), adipose (A); malignant tissue consists of invasive ductal carcinoma (IDC) and ductal carcinoma in situ
(DCIS). All malignant tissues were stratified according to depth: positive (0 mm), close within 1 mm (0
+ to 1 mm), close between 1 and 2 mm
(1
+ to 2 mm). DCIS (0 mm) is not shown due to its small sample size (n = 2).
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Page 7 of 132 mm) (8.31 cm
-1 ±1 . 5 2 MAD). In contrast, [b-carotene]
followed an increasing trend with increased distance of
malignancy; it was highest in close sites (1
+ to 2 mm)
(19.00 μM ± 7.81MAD), followed by close sites (0
+ to
1 mm) (15.59 μM ± 9.53MAD), then positive sites (0 mm)
(13.89 μM ± 6.23MAD). Lastly, the concentration of total
hemoglobin was found to decrease as follows: positive
(92.57 μM ± 18.46MAD), close (1
+ to 2 mm) (36.98 μM±
18.24MAD), and close (0
+ to 1 mm) (36.08 μM±
12.81MAD). [THb] showed statistical significant differ-
ences between positive sites (0 mm) and FG (un-adj. P =
0.0069), FA (adj. P = 0.0037) and A (adj. P = 0.0004), as
well as between close sites (0
+ to 1 mm) and A (P =
0.0036) when corrected for nine comparisons. The other
optical parameters did not show differences that were
statistically significant after accounting for multiple com-
parisons. However, the trends demonstrate that the med-
ian and MAD of the optical parameters were affected by
the depth of disease and the unknown intervening tissue.
The depth analysis shows that depth plays an important
role but due to the small sample size it is not possible to
specifically indicate how depth affects each disease type.
Optical contrast: menopausal status and normal variants
A total of 45 optical sites were excluded from this part
of the analysis due to the patients having an undefined
menopausal status (lack of menses in patients younger
than 40 years of age; peri-menopausal or unknown
menopausal status). The malignant sites could not be
analyzed by menopausal status because of the low num-
ber of malignant sites from pre-menopausal patients.
The relative frequency of adipose tissue is higher in
post-menopausal patients while the relative frequency of
fibro-glandular tissue is higher in pre-menopausal
patients. The histograms in Figure 4 represent A) the
percentage of the sites from pre-menopausal patients
that were composed of FG, FA and A sites, and B) the
percentage of the sites from post-menopausal patients
that were composed of the same three tissue types.
Regardless of menopausal status, adipose tissue was
s h o w nt ob et h em o s tl i k e l yt i s s u et y p eo nam a r g i n
accounting for 80% of the combined total 373 sites.
However, differences were observed in the relative con-
tributions of normal tissue types between pre- and post-
menopausal patients. The post-menopausal women
showed 84% adipose sites, 15% fibro-adipose sites and
1% fibro-glandular sites. Pre-menopausal women, how-
ever, showed 66% adipose sites, 14% fibro-adipose sites,
and 20% fibro-glandular sites.
In order to verify that the measured optical variability
was due to differences in the relative amounts in tissue
composition and not inherent differences in tissue opti-
cal properties with menopausal status, we compared the
optically measured parameters in purely adipose sites
between pre- and post-menopausal patients. The optical
parameters from pure adipose sites were compared
between pre- and post-menopausal patients and neither
scattering (Pre-menopause: 7.54 cm
-1 ±2 . 4 8 MAD,P o s t -
menopause: 6.27 cm
-1 ± 2.36MAD) nor [b-carotene] (Pre-
menopause: 18.50 μM ± 7.39MAD,P o s t - m e n o p a u s e :
18.77 μM±7 . 6 1 3 MAD) showed statistical differences
between pre- and post-menopausal adipose sites. [THb],
however, was lower in post-menopausal adipose sites
which may be in part to differences in specimen bleed-
ing or decreased overall blood volume (Pre-menopause:
44.16 μM±2 2 . 0 6 MAD, Post-menopause: 27.83 μM±
21.67MAD).
The comparison of all normal sites from pre-versus
post-menopausal patients showed decreased scattering
(P < 0.0001) (Figure 5A), increased [b-carotene] (P <
0.0001) (Figure 5B), and decreased [THb] (Figure 5C)
(P = 0.0091) in post-menopausal sites (< μs’ > : 6.62 cm
-
1 ± 2.60MAD, [THb]: 31.43 μM ± 24.16MAD, and [b-caro-
tene]: 18.38 μM ± 8.42MAD) compared to pre-menopau-
sal sites (< μs’ >: 8 . 5c m
-1 ±3 . 4 9 MAD,[ T H b ] :4 1 . 3 9μM
± 26.97MAD,a n d[ b-carotene]: 4.84 μM ± 7.72MAD).
This was consistent with increased fibrous content in
pre-menopausal women and increased adipose content
in post-menopausal women. Thus, the trends for
scattering and [b-carotene] seen in normal sites from
pre- and post-menopausal further confirmed the predo-
minant tissue types suspected with each demographic
category.
Discussion
There are two ways to approach the problem with accu-
rate intra-operative breast margin assessment: a whole
margin-level method where summary measures are
created to describe multiple pixels on a margin and sec-
ondly, a site-level approach using pathologically con-
firmed individual pixels. We have previously published
accuracy results on the margin-level classification. This
paper is aimed at understanding the optical contrast
from individual pixels which will be informative for
both methods of assessment. We hypothesized that the
heterogeneity of normal breast tissues, the distance of
malignant cells from a margin and menopausal status
would each influence the interpretation of optical mea-
surements of changes within a breast specimen. Despite
the heterogeneity of normal tissue composition, signifi-
cant differences between all malignant and normal tis-
sues were observed for < μs’> and [THb]. Both of these
optical parameters were increased in malignant sites
compared to normal sites. Several studies have seen
increased scattering in malignant tissues compared to
normal tissues [32,36,39,40]. Pogue et al.d e t e r m i n e d
that total hemoglobin-based contrast can be up to 200%
higher in cancer relative to the normal background [41].
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studies for < μs’> and [THb]. [b-carotene] did not differ-
entiate between benign and malignant sites in our study
in contrast to Volynskaya et al., who found [b-carotene]
in bread-loafed specimens (rather than margins) to be
higher in normal (fattier) tissues compared to that in
tissues with invasive carcinoma [29]. Tissue type has
been previously shown to affect optical properties.
Breast tissue is heterogeneous such that ex-vivo sites
will have very different tissue composition depending on
the number of malignant cells within an examined
volume. The prevalence or probability of seeing a cer-
tain tissue type can be related to patient demographics.
Thus, we hypothesized that optical contrast could be
modulated by tissue composition, distance from the
margins and patient demographics, specifically meno-
pausal status.
Scattering variations in normal tissue: our analysis
showed that scattering increased as fibrous content
increased and adipose content decreased, within normal
tissue types consistent with previous studies. Scattering
in normal tissues has previously been shown to be
negatively correlated with the amount of adipose tissue
present [36]. Srinivasan et al. found that adipose tissues
had low scattering power in the near infrared spectrum
(NIR) due to large scatterers, while glandular or fibrous
(or by extension fibro-glandular) tissues had high scat-
tering power resulting from more cellular and collagen-
based structures [42]. Fibro-glandular tissue is composed
of fibroblasts, collagen and elastin bundles, interspersed
with ducts/lobules and minimal adipose tissue. In con-
trast, adipose tissue is comprised of many adipocytes
containing lipid droplets with the nucleus flattened
along the periphery of the cell resulting in fewer scatter-
ing events. Fibro-adipose tissue is a combination of adi-
pocytes and collagen bundles so the resulting scattering
falls between the values seen for fibrous and adipose tis-
sue separately. These three normal tissue types exhibited
< μs’> values that were significantly different from one
another; in summary < μs’> describes the presence or
absence of fibrous tissue which, in turn, will be related
to a patient’s demographic factors.
b-carotene and hemoglobin in normal tissues: [b-
carotene] has previously been positively correlated with
Figure 4 Histograms of the percent composition of the three main normal tissue types. The fibro-glandular (FG), fibro-adipose (FA) and
adipose (A) sites were stratified by (A) pre-menopausal sites and (B) post-menopausal sites.
Figure 5 Boxplots of the extracted parameters from normal sites (n = 553).T h eo p t i c a lp r o p e r t i e s(A) < μs’ >, (B) [b-carotene], and (C)
[THb] previously shown in Figure 2 now stratified according to menopausal status. Post-menopausal patients exhibited lower < μs’> and [THb]
(panels A. and C.) but higher [b-carotene] (panel C.) than pre-menopausal patients.
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Page 9 of 13adipose tissue [36]. [b-carotene] in this study, was also
found to increase along with an increasing amount of
adipose tissue (that is, from fibro-glandular, to fibro-
adipose, to adipose). Hemoglobin volume was found to
be decreased in adipose tissue compared to other nor-
mal tissue types [43-45]. The trends seen in our study
indicated a slight decrease in [THb] for adipose com-
pared to fibro-glandular tissues but the comparisons
were not statistically significant. [b-carotene] may pro-
vide more information related to the amount of adi-
pose tissue in normal tissues, but [THb] is less
susceptible to variations in normal tissue types and
will most likely only be informative for distinguishing
very vascular malignant sites from avascular normal
sites.
The sources of underlying optical contrast were first
examined across the normal and malignant variants
inclusive of all disease depths. Diagnosing malignant tis-
sues: [THb] and < μs’> exhibited the greatest differences
between malignant (IDC and DCIS) and adipose tissues,
while [b-carotene] only showed statistical differences
between normal tissue types. Prior to correcting the
p-values for multiple comparisons, < μs’>w a ss t a t i s t i -
cally lower in IDC compared to FG with and DCIS
exhibited statistically higher [b-carotene] than FG and
statistically higher [THb] compared to FA. [THb] was
still not statistically higher in IDC than FG since FG is
not as avascular as A. The correction factor can cause
observed true differences to be rejected; thus we believe
that [b-carotene] and [THb] in additional to < μs’ >, are
worth pursuing further for margin assessment. Distin-
guishing malignant tissue from normal variants is a clin-
ical challenge due to the known heterogeneity in tumors
and the normal micro-environment (pathology). Histolo-
gically, IDC presents itself as cancerous cells that have
invaded through the basement membrane into the sur-
rounding stroma. These cancerous cells are also sur-
rounded by a fibro-vascular matrix that displaces
adipocytes. Because FG (and often FA) tissues can exhi-
bit fibrous and vascular structures, it may be difficult to
differentiate IDC from FG or FA based on < μs’>a l o n e
as reflected by the statistical findings. [b-carotene] is not
a source of contrast either since both IDC and FG have
minimal adipose tissue content. [THb] cannot differenti-
ate IDC from FG most likely because both tissue types
are well vascularized and because IDC includes all
depths of disease. DCIS is comprised of a combination
of malignant cells, a fibrous component, and adipocytes.
Because of the surrounding normal tissue, DCIS could
not be discriminated from FG or FA sites using < μs’>
as mentioned above. For the same reasons, it is also dif-
ficult to differentiate DCIS from adipose tissue using [b-
carotene]. However, it is possible to use [b-carotene] to
separate DCIS from FG as it is possible to differentiate
DCIS from adipose tissues using < μs’ >. The optical
contrast for DCIS and IDC compared to the normal var-
iants were similar with the exception of FG; DCIS
showed differences from FG using [b-carotene] but
none of the parameters separated IDC from FG. This
lack of contrast between IDC and FG is a function of
n o to n l yt i s s u et y p eb u ta l s ot h ed e p t ho fd i s e a s ea n d
the intervening normal tissue.
When distance from the margin was included in the
analysis, it became apparent that the distance of inter-
vening normal tissue impacted the extracted optical
properties. The trends indicated that scattering
increased and [b-carotene] decreased in all close (0
+ to
1 mm) compared to positive (0 mm) sites which sug-
gests of the presence of intervening fibrous tissue. In
contrast, [b-carotene] was higher while scattering was
lower in close sites (1
+ to 2 mm) compared to close
sites (0
+ to 1 mm), indicative of fatty tissue. [THb] was
found to be the highest in positive tissues. For sites with
close margins, the contrast will be dependent on the
intervening normal tissue. The type of intervening nor-
mal tissue will be related to the demographic factors.
For positive margins however, [THb] shows potential
for separating positive sites (IDC and DCIS) from FA
and A, as well as from FG. It is clear that the amount
and type of normal tissue present between the margin
and the malignant cells impacts optical contrast. The
complex heterogeneity of intervening tissue increases
the difficulty of separating malignant from normal
tissues.
Our results show that the frequency and predomi-
nance of tissue types on a margin is related to a
patient’s menopausal status. Post-menopausal patients
exhibited a higher frequency of adipose (A) sites and a
lower frequency of fibro-glandular (FG) sites compared
to pre-menopausal patients. Pre-menopausal women
are expected to have denser breast tissue, while post-
menopausal women typically have fattier breasts. Cerussi
et al. looked at the optical properties of breast tissue in
the NIR and found pre-menopausal women had higher
scattering values and concentrations of THb, but lower
lipid content ([b-carotene]) compared to post-menopau-
sal subjects [46]. The trends in this study are consistent
with the results observed previously. Suzuki et al.s t u -
died the optical properties of 30 Japanese women and
reported a strong negative correlation of absorption and
scattering properties with age, BMI and menstrual status
[43]. Cubeddu et al. reported changes with age, which
could be attributed to tissue fat content [47]. All normal
sites were found to demonstrate increased [b-carotene]
and decreased < μs’> in post-menopausal patients rela-
tive to scattering in pre-menopausal patients.
As shown in this study, menopausal status does not
affect the optical properties of individual tissue types,
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whole. The site level analysis demonstrated that < μs’>
would be the best variable for differentiating cancer
against a fatty background and [b-carotene] would be
useful in separating DCIS from fibrous tissues. Due to
tissue vascularity, malignant tissues with significant vas-
culature or angiogenesis will show the best contrast
with [THb]. For positive margins, [THb] would be effec-
tive in separating positive sites (IDC and DCIS) from
FG, FA and A. Thus, [THb] has potential for discrimi-
nating malignancy at the margin from a fibrous back-
ground. For margin assessment, it is necessary to
discriminate cancer from the surrounding background;
we have demonstrated that a patient’s menopausal status
will help define the surrounding normal variants allow-
ing the correct optical variable to be applied.
In summary, it is important to understand the underly-
ing sources of contrast when using optical spectroscopy
for applications to breast tissue. Our results indicate that
steps need to be taken to utilize a patient’s demographics
to individualize care and optical evaluation. The normal
variants on a margin have the potential to decrease the
sensitivity and specificity of optical techniques for identi-
fying malignancy. Tailoring optical evaluation to the
demographics of a patient may provide a means to
account for the normal heterogeneity of the breast and
facilitate differentiation between benign and malignant
changes in patients undergoing breast conservation ther-
apy for the treatment of breast cancer. Future studies will
incorporate these patient demographic variables into the
optical assessment to determine which parameters would
be best utilized for margin assessment.
Conclusions
This observational study shows that menopausal status and
patient demographics will be a factor in maximizing the
diagnostic capabilities of optical spectroscopy for breast
cancer margin assessment. The site level analysis demon-
strates which variables are best at discriminating cancer
against a fatty background and against a fibrous back-
ground. The correct variables for margin level assessment
can then be chosen after taking patient demographics into
account to determine which tissue background will be
encountered. We found scattering to be the most effective
in post-menopausal women and [b-carotene] or [THb] to
be effective in pre-menopausal women.
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